Results 241 to 246 of about 38,316 (246)

HCB101: a novel potent ligand-trap Fc-fusion protein targeting the CD47-SIRPα pathway with high safety and preclinical efficacy for hematological and solid tumors. [PDF]

J Hematol Oncol
Wang JT, Tseng CL, Teng HF, Kuo PH, Cheng YC, Chen YJ, Lu YH, Wang CC, Shen TK, Wang HF, Tsai PL, Wu YC, Ho CH, Sun WT, Li YC, Lee YH, Hung YJ, Chen M, Li Z, Juo ZS, Zhai W, Liu SS.   +21 more
europepmc   +1 more source

A bufalin and CRISPR/Cas9 ribonucleoprotein-loaded calcium lactate nanomedicine for pyroptosis/apoptosis and synergistic cancer immunotherapy. [PDF]

Mater Today Bio
Liu Y, Hou D, Wang H, Yan Q, Xu Y, Wu Q, Dong D, Shen W, Tao W, Cheng H, Sun D.   +10 more
europepmc   +1 more source

Engineered macrophages accumulate in solid tumors and locally deliver immune-activating proteins to inhibit tumor progression. [PDF]

Transl Cancer Res
Xu Y, Zhou Y, Wang J.
europepmc   +1 more source

Synergistic fusion of CD47, VE-cadherin and mussel adhesion protein promotes endothelialization and suppresses inflammation in vascular stents. [PDF]

Bioact Mater
Yan W, Li S, Zhang T, Huang J, Deng C, Yuan K, Huang N, Zhang H, Wang G.   +8 more
europepmc   +1 more source

Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond

Amber Afzal, Zobia Afzal, Sophia Bizink, Amanda L. Davis, Sara Makahleh, Yara Mohamed, Salvatore J. Coniglio   +6 more
openalex   +2 more sources

Functional Analysis of CD47/IAP in Cultured Central Nervous System Neurons [PDF]

コシミズ, ヒサツグ, 小清水, 久嗣   +1 more
core